ORG Wealth Partners LLC Trims Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

ORG Wealth Partners LLC cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 41.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 975 shares of the financial services provider’s stock after selling 696 shares during the quarter. ORG Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $129,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. International Assets Investment Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $433,000. CWA Asset Management Group LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $382,000. Modus Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $41,000. Franklin Resources Inc. grew its position in shares of iShares Biotechnology ETF by 3.3% in the 3rd quarter. Franklin Resources Inc. now owns 18,285 shares of the financial services provider’s stock worth $2,664,000 after buying an additional 580 shares during the period. Finally, Wilmington Savings Fund Society FSB purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter worth about $263,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $132.73 on Friday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The company’s 50-day moving average is $138.16 and its 200 day moving average is $142.00.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.